New York 2025-2026 Regular Session

New York Senate Bill S01862

Introduced
1/14/25  
Refer
1/14/25  

Caption

Provides for the proper packaging and labeling of pharmaceutical drugs; creates penalties for intentional fraudulent replacement, packaging, and labeling of such drugs; provides for better consumer protection.

Companion Bills

No companion bills found.

Previously Filed As

NY SB2395

Food labeling; require disclosure of certain ingredients on food packaging and provide consumer notice disclaimer.

NY HB4252

Health: pharmaceuticals; labeling of generic name on pharmaceutical blister packaging; require under certain circumstances. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17748g.

NY S08136

Relates to enacting the New York state kratom consumer protection act; relates to labeling and other requirements for the sale of kratom products.

NY A08693

Relates to enacting the New York state kratom consumer protection act; relates to labeling and other requirements for the sale of kratom products.

NY HB0014

FOOD & DRUG-BEEF PACKAGING

NY S3632

Increases and modifies certain fees and penalties regarding weighing, measuring, labeling, packaging, and inspection of certain commodities and commercial products.

NY HB646

AN ACT relating to the use of pharmaceuticals to intentionally terminate life.

NY SB292

Prohibiting the transfer of hemp-derived cannabinoid products to any person under the age of 21, establishing packaging and labeling requirements for such products and amending the definition of industrial hemp and hemp products.

NY HB1357

Consumer Protection - Menstrual Hygiene Products - Labeling Requirements

NY S01464

Enacts the "packaging reduction and recycling infrastructure act" to require companies selling, offering for sale, or distributing packaging materials and products to register with a packaging reduction organization to develop a packaging reduction and recycling plan; makes related provisions.

Similar Bills

NJ A538

"Pharmaceutical Representative Licensing Act."

AR HB1301

To Amend The Prior Authorization Transparency Act.

CT SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

NJ S2894

Establishes New Jersey Active Pharmaceutical Ingredient Regulatory Commission.

KY SB2

AN ACT relating to correctional facilities.

NJ S2990

Regulates provision of pharmaceutical services in long-term care facilities.

NJ A3359

Regulates provision of pharmaceutical services in nursing homes.

FL S0860

Compounded Drugs